<p>Chronic hyperglycemia in diabetes precipitates vascular damage and subsequent organ failure, yet the most critical defect is the inability to mount an adequate regenerative response. Numerous studies confirm that the reparative process, particularly angiogenesis, is profoundly defective in patients with diabetes. An increasingly vital area of investigation focuses on vasculogenesis: the <i>de novo</i> formation of blood vessels, involving specialized stem/progenitor cells. When these crucial repair cells and processes fail, complications in the target organ become inevitable and often irreversible. This review synthesizes our current understanding of how the complex diabetic milieu, marked by inflammation and metabolic stress, fundamentally corrupts the function, mobilization, and survival of these essential vascular regenerative populations. We highlight the known molecular mechanisms underlying this failure and, critically, examine emerging strategies to normalize these cellular abnormalities. Restoring robust vasculogenesis represents the next frontier in therapeutic development, holding the key to enhancing endogenous repair and successfully engineering new, functional vasculature to combat diabetic tissue damage.</p>